Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-56808

ABSTRACT: Transcription profiling by array of fibroblasts derived from skin biopsies taken from sporadic amyotrophic lateral sclerosis and primary lateral sclerosis neurologically normal human controls

PROVIDER: E-GEOD-56808 | ExpressionAtlas | 2025-01-24

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-GEOD-56808-analysis-methods.tsv	Tabular
	E-GEOD-56808-atlasExperimentSummary.Rdata	Rdata
	E-GEOD-56808-configuration.xml	Xml
	E-GEOD-56808-percentile-ranks.tsv	Tabular
	E-GEOD-56808.condensed-sdrf.tsv	Tabular

Items per page:

1 - 5 of 62

Similar Datasets

Gene expression signatures in motor neuron disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions

Project description:Amyotrophic lateral sclerosis and primary lateral sclerosis are two syndromic variants within the motor neurone disease spectrum. Whilst primary lateral sclerosis is associated with loss of upper motor neurons and a more benign disease course up to 17yrs, amyotrophic lateral sclerosis is caused by loss of both upper and lower motor neurons and has an average disease course of 2-3 years. The majority of cases are sporadic, thereby limiting the availability of cellular models for investigating pathogenic disease mechanisms. The aim of the present study was to evaluate fibroblasts as a cellular model for sporadic amyotrophic lateral sclerosis and primary lateral sclerosis, to establish whether disease-related dysregulated biological processes recapitulate those seen in the central nervous system and to elucidate pathways that distinguish between the two disease phenotypes. We used microarray analysis to determine the differences in gene expression between fibroblasts derived from skin biopsies taken from sporadic amyotrophic lateral sclerosis and primary lateral sclerosis neurologically normal human controls

2014-04-16 | E-GEOD-56808 | biostudies-arrayexpress

C9ORF72 repeat expansion affects the proteome of primary skin fibroblasts in ALS and FTD

Project description:The study design involves the proteomics characterization of primary skin fibroblast cell lines derived from skin biopsies from patients affected by either amyotrophic lateral sclerosis (ALS) or frontotemporal dementia (FTD). Patients enrolled were divided in three groups: 1) ALS patients carrying the C9ORF72 repeat expansion as main genetic mutation (c9orf72 pos; n=6), 2) sporadic ALS patients, carrying mutations other than the C9ORF72 repeat expansion (c9orf72 neg; n=8), 3) FTD patients carrying the C9ORF72 repeat expansion (FTD; n=2). Total protein extracts were obtained from primary skin fibroblasts cultures and trypsin digested. Shotgun proteomics by LC-MS/MS (two technical replicates per sample) and systems biology analyses were performed as follows

2021-11-02 | PXD023866 | Pride

Gene expression signatures in motor neuron disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions

2014-04-16 | GSE56808 | GEO

RNA sequencing of motor neurons derived from induced pluripotent stem cells of ALS patients with the M337V mutation in TARDBP

Project description:Sequencing of human iPS-derived motor neurons from fibroblasts of Amyotrophic lateral sclerosis patients with an M337V mutation in TARDBP and comparison with age matched healthy controls identify differences in glutamate receptor and mitochondrial calcium buffering channels.

2020-03-26 | GSE147544 | GEO

E-GEOD-51518

Project description:RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age

2025-01-24 | E-GEOD-51518 | ExpressionAtlas

Muscle Gene Expression Is a Marker of Amyotrophic Lateral Sclerosis Severity

Project description:This study was designed to identify gene expression changes in skeletal muscle that could define reliably the degree of the severity of Amyotrophic lateral sclerosis (ALS). All samples were from human biopsies, either from healthy muscles or from muscle whose patients were clearly diagnosed as having Amyotrophic Lateral Sclerosis (ALS)

2012-01-17 | E-MEXP-3260 | biostudies-arrayexpress

Als2

Project description:Drosophila melanogaster Als2, Amyotrophic lateral sclerosis 2, is differentially expressed in 14 experiment(s);

| FBgn0037116 | ExpressionAtlas

Als2

Project description:Drosophila melanogaster Als2, Amyotrophic lateral sclerosis 2, is expressed in 5 baseline experiment(s);

| FBgn0037116 | ExpressionAtlas

Homo sapiens

Project description:Amyotrophic lateral sclerosis

| PRJNA87835 | ENA

Homo sapiens

Project description:Amyotrophic Lateral Sclerosis